| Breakdown | TTM | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.13M | 57.82M | 45.87M | 22.83M | 6.98M | 2.66M |
| Gross Profit | 31.15M | 36.98M | 24.11M | 14.71M | 5.08M | 1.88M |
| EBITDA | 10.10M | 8.49M | 7.35M | 6.52M | 2.30M | -1.85M |
| Net Income | -886.00K | -1.25M | -336.00K | -994.00K | -874.00K | -6.58M |
Balance Sheet | ||||||
| Total Assets | 84.95M | 81.61M | 73.15M | 61.91M | 48.97M | 11.38M |
| Cash, Cash Equivalents and Short-Term Investments | 4.52M | 1.09M | 3.94M | 3.19M | 8.22M | 2.72M |
| Total Debt | 46.83M | 43.23M | 33.68M | 25.52M | 10.06M | 4.03M |
| Total Liabilities | 63.01M | 57.83M | 48.14M | 40.31M | 27.15M | 6.17M |
| Stockholders Equity | 21.95M | 23.78M | 25.00M | 21.60M | 21.82M | 5.20M |
Cash Flow | ||||||
| Free Cash Flow | 1.06M | -55.00K | 3.29M | -5.89M | -1.96M | -3.30M |
| Operating Cash Flow | 7.68M | 7.63M | 10.72M | 3.32M | 742.00K | -1.26M |
| Investing Cash Flow | -6.41M | -7.30M | -6.19M | -6.59M | -11.91M | -2.03M |
| Financing Cash Flow | 1.39M | -3.17M | -3.77M | -1.78M | 16.67M | 3.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £3.44B | 26.72 | 17.89% | 1.21% | 14.60% | 58.84% | |
64 Neutral | £620.65M | -23.98 | 4.40% | 3.36% | -2.59% | -46.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | £20.34M | 17.87 | 5.63% | ― | -6.24% | -82.21% | |
52 Neutral | £259.19M | -1.12 | -111.93% | ― | -14.89% | 12.08% | |
47 Neutral | £22.33M | -3.21 | -5.08% | ― | 20.40% | -271.43% | |
41 Neutral | £260.43M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |